Hepatitis B and HIV co-infection- experience in a rurul/suburban health center in Nigeria

Salami T. AT, Babatope I. O, Adewuyi G. M, Samuel S. O, Echekwube P. O


Hepatitis B virus shares similar transmission patterns and risk factors with the human immune deficiency (HIV) virus. Both are endemic in Nigeria and co infection is likely. All adult patients that are HIV positive seen in the adult ART clinic over a six month period were investigated for hepatitis B infection by screening for hepatitis B surface antigen (HBsAG) as well as other baseline investigation such as CD4 count. There were 53 patients that tested positive for HBSAG out of a total of 1800 HIV positive patients enrolled in care during this period, giving a co infection prevalence rate of 3.2%. There were 36 males and 21 females, giving a male: female ratio of 1.7:1. The mean age was 36 ±16.6. The co infection rate in this centre is lower to that reported in other centres perhaps because of the suburban location of Irrua Specialist Teaching Hospital, Irrua. The sex distribution and CD4 counts are however similar to that reported by other studies.


Key Words: Hepatitis B, HIV co-infection. rural/sub urban, health centre.

Full Text:



. Benhamou Y.(2007). J Acquir Immune Defic Syndr.;45 (2):66-67.

. Hoffmann CJ, Thio CL. (2007). Lancet Infect Dis.;7:402–409.

. Lavanchy D. (2004). Journal of Viral Hepatitis;11:97–107

. Okogbo F.O, Aisabokhale F.A, Dada F.L.( 2004). Journal of Applied and Basic Science;2(1&2):33-35.

. Okokhere P.O, Babatope I.O, Gborogen E.E. (2009). Journal of Applied and Basic Science;5:50-52.

. M. N. Charan Paul et al Der Pharmacia Lettre, 2012, 4 (4):1270-1271

. Shazia Parveen. S et al J. Microbiol. Biotech. Res., 2012, 2 (2):343-345

. Ejele OA, Nwauche CA, Erhabor O( 2004). Niger J Med;13(2):175-179.

. Idoko J, Meloni S, Muazu M, Nimzing L, Badung B et al. (2009). Clin Infect Dis ;49(8):1268-1273.

. Nwokedi EE, Emokpae MA, Dutse AI.( 2006) Niger J Med;15(3):227-229.

. Iwalokun BA, Hodonu SO, Olaleye BM, Olabisi OA. (2006) Afr J Med Med Sci. 2006;35(3):337-343.

.Lesi OA, Kehinde MO, Oguh DN, Amira CO. (2007). Niger Postgrad Med J;14(2):129-133.

. Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S et al(2008). Ann Hepatol;7(2):152-156.

.Geretti AM, Patel M, Sarfo FS, Chadwick D, Verheyen J, Fraune M et al(2010). J Clin Microbio. [Epub ahead of print]

. Rouet F, Chaix ML, Inwoley A, Anaky MF, Fassinou P, Kpozehouen A et al(2008). Clin Infect Dis;46(3):361-366.

.Konopnicki D, Mocroft A, de Wit S, Antunes F, Ledergerber B, Katlama C, et al(2005). AIDS;19(6):593-601.

. Salami T.A, Samuel S.O, Oziegbe O.E, Eze K.C. (2008). African Journal of Clinical and experimental microbiology; 9(1):33-37.

. Gupta S, Singh S.(2010). BMC Infect Dis;10:53.

. Yako AB et al Annals of Biological Research, 2011, 2 (3):17-24

. Psevdos G Jr, Kim JH, Suh JS, Sharp VL. (2010). World J Gastroenterol;16(9):1093-1096.

. Hoffmann CJ, Charalambous S, Martin DJ, Innes C, Churchyard GJ et al (2008). Clin Infect Dis;47(11):1479-

. Mallet VO, Dhalluin-Venier V, Verkarre V, Correas JM, Chaix ML, Viard JP et al. (2007). Antivir Ther;12(2):279-283.

. Hoffmann CJ, Charalambous S, Thio CL, Martin DJ, Pemba L, Fielding KL et al. (2007) AIDS;21(10):1301-1308.

. Adebajo AO, Smith DJ, Hazleman BL, Wreghitt TG. (1994). J Med Virol;42(4):366-368.

. Dieterich DT. (2007). Antivir Ther;12 Suppl 3:43-51.

.Nelson, M., S. Portsmouth, J. Stebbing, M. Atkins, A. Barr, G. Matthews et al. (2003). AIDS .2003;17:7-10.

. Ristig, M. B., J. Crippin, J. A. Aberg, W. G. Powderly, M. Lisker-Melman, L. Kessels, and P. Tebas (2002) J. Infect. Dis;186:1844-1847.

Copyright (c) 2017 Journal of Microbiology and Biotechnology Research

<Microbiology+Biotechnology+Research>Journal of Microbiology and Biotechnology Research